2020 Q1 Form 10-Q Financial Statement

#000156459020024212 Filed on May 11, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q4 2019 Q1
Revenue $6.564M $6.475M
YoY Change 1.37%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $560.0K $310.0K $290.0K
YoY Change 93.1% 3.33% -6.45%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $1.189M $907.0K
YoY Change 31.09%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $1.736M $1.780M $1.532M
YoY Change 13.32% -14.83% -56.1%
Income Tax $332.0K $350.0K $286.0K
% Of Pretax Income 19.12% 19.66% 18.67%
Net Earnings $1.404M $1.430M $1.246M
YoY Change 12.68% -14.88% -55.44%
Net Earnings / Revenue 21.39% 19.24%
Basic Earnings Per Share $0.52 $0.46
Diluted Earnings Per Share $0.52 $531.6K $0.46
COMMON SHARES
Basic Shares Outstanding 2.693M 2.678M
Diluted Shares Outstanding 2.694M 2.687M

Balance Sheet

Concept 2020 Q1 2019 Q4 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $135.4M $134.8M
YoY Change 64.5%
Cash & Equivalents $31.57M $19.09M $14.60M
Short-Term Investments $103.8M $115.7M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $5.955M $6.145M $11.00M
YoY Change -45.86% -12.74% 54.93%
Goodwill $372.0K $372.0K
YoY Change 0.0%
Intangibles $391.0K $408.0K
YoY Change -14.47%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $717.1M $702.6M $635.8M
YoY Change 12.79% 8.97% 1.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.200M $1.700M $2.000M
YoY Change 10.0% 13.33% -13.04%
Accrued Expenses $3.400M $3.600M $4.100M
YoY Change -17.07%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.600M $5.300M $6.100M
YoY Change -8.2% 253.33% 165.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.600M $5.300M $6.100M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $640.8M $626.5M $563.3M
YoY Change 13.76% 9.14% 0.82%
SHAREHOLDERS EQUITY
Retained Earnings $37.83M $37.24M
YoY Change -3.65%
Common Stock $6.720M $6.720M
YoY Change 5.68%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $76.29M $76.11M $72.53M
YoY Change
Total Liabilities & Shareholders Equity $717.1M $702.6M $635.8M
YoY Change 12.79% 8.97% 1.65%

Cashflow Statement

Concept 2020 Q1 2019 Q4 2019 Q1
OPERATING ACTIVITIES
Net Income $1.404M $1.430M $1.246M
YoY Change 12.68% -14.88% -55.44%
Depreciation, Depletion And Amortization $560.0K $310.0K $290.0K
YoY Change 93.1% 3.33% -6.45%
Cash From Operating Activities $2.891M $4.750M $2.713M
YoY Change 6.56% 66.08% -35.56%
INVESTING ACTIVITIES
Capital Expenditures $89.00K -$70.00K $64.00K
YoY Change 39.06% -41.67% -420.0%
Acquisitions $50.00K $50.00K
YoY Change 0.0%
Other Investing Activities -$3.430M -$54.41M $9.080M
YoY Change -137.78% 523.97% 65.39%
Cash From Investing Activities -$3.519M -$54.48M $9.012M
YoY Change -139.05% 517.69% 65.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 13.12M 40.96M -16.00M
YoY Change -182.01% 154.88% -23.98%
NET CHANGE
Cash From Operating Activities 2.891M 4.750M 2.713M
Cash From Investing Activities -3.519M -54.48M 9.012M
Cash From Financing Activities 13.12M 40.96M -16.00M
Net Change In Cash 12.49M -8.770M -4.270M
YoY Change -392.48% -186.75% -62.45%
FREE CASH FLOW
Cash From Operating Activities $2.891M $4.750M $2.713M
Capital Expenditures $89.00K -$70.00K $64.00K
Free Cash Flow $2.802M $4.820M $2.649M
YoY Change 5.78% 61.74% -37.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001572334
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
Virginia National Bankshares Corp
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2020Q1 dei Entity File Number
EntityFileNumber
000-55117
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
VA
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei City Area Code
CityAreaCode
434
CY2020Q1 dei Trading Symbol
TradingSymbol
VABK
CY2020Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
404 People Place
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
VA
CY2020Q1 us-gaap Goodwill
Goodwill
372000
CY2020Q1 us-gaap Liabilities
Liabilities
640808000
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
391000
CY2020Q1 us-gaap Other Assets
OtherAssets
9243000
CY2020Q1 us-gaap Assets
Assets
717099000
CY2020Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
190618000
CY2020Q1 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
124350000
CY2020Q1 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
218432000
CY2020Q1 us-gaap Time Deposits
TimeDeposits
101736000
CY2020Q1 us-gaap Deposits
Deposits
635136000
CY2020Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
5672000
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
5309000
CY2019Q4 us-gaap Liabilities
Liabilities
626520000
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
2.50
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
2.50
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 dei Entity Bankruptcy Proceedings Reporting Current
EntityBankruptcyProceedingsReportingCurrent
true
CY2020Q1 us-gaap Cash And Due From Banks
CashAndDueFromBanks
19312000
CY2020Q1 us-gaap Federal Funds Sold
FederalFundsSold
12262000
CY2020Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
102054000
CY2020Q1 us-gaap Restricted Investments
RestrictedInvestments
1736000
CY2020Q1 us-gaap Marketable Securities
MarketableSecurities
103790000
CY2020Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
553959000
CY2020Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
4704000
CY2020Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
549255000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5955000
CY2020Q1 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
16519000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2692005
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2702373
CY2019Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
4000
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
6720000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
37235000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32195000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
37828000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-491000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
76291000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
717099000
CY2020Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
5871000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
6720000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-43000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
76107000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
702627000
CY2019Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
6097000
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
32234000
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2331578
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Charlottesville
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
22911
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
14368
CY2019Q1 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
19000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2702373
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
754000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
754000
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2000000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
201000
CY2019Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
0
CY2020Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1287
CY2019Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
8914
CY2019Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
114041000
CY2019Q4 us-gaap Restricted Investments
RestrictedInvestments
1683000
CY2019Q4 us-gaap Marketable Securities
MarketableSecurities
115724000
CY2019Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
539533000
CY2019Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
4209000
CY2019Q4 us-gaap Goodwill
Goodwill
372000
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
408000
CY2019Q4 us-gaap Other Assets
OtherAssets
9157000
CY2019Q4 us-gaap Assets
Assets
702627000
CY2019Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
166975000
CY2019Q4 us-gaap Interest Bearing Deposit Liabilities
InterestBearingDepositLiabilities
122994000
CY2019Q4 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
221964000
CY2019Q4 us-gaap Time Deposits
TimeDeposits
109278000
CY2019Q4 us-gaap Deposits
Deposits
621211000
CY2019Q4 us-gaap Federal Funds Sold
FederalFundsSold
4177000
CY2019Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
535324000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6145000
CY2019Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
16412000
CY2019Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
14908000
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2704273
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
817-8621
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2692005
CY2020Q1 us-gaap Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
85000
CY2020Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
509000
CY2020Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
75000
CY2020Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
24000
CY2020Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
6564000
CY2020Q1 vabk Interest Expense Demand And Savings Deposits
InterestExpenseDemandAndSavingsDeposits
695000
CY2019Q1 vabk Interest Expense Demand And Savings Deposits
InterestExpenseDemandAndSavingsDeposits
381000
CY2020Q1 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
494000
CY2019Q1 us-gaap Interest Expense Federal Funds Purchased And Securities Sold Under Agreements To Repurchase
InterestExpenseFederalFundsPurchasedAndSecuritiesSoldUnderAgreementsToRepurchase
67000
CY2020Q1 us-gaap Interest Expense
InterestExpense
1189000
CY2019Q1 us-gaap Interest Expense
InterestExpense
907000
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5375000
CY2019Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5568000
CY2020Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
765000
CY2019Q1 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
684000
CY2020Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
4610000
CY2019Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
4884000
CY2020Q1 vabk Trust Income
TrustIncome
310000
CY2019Q1 vabk Trust Income
TrustIncome
347000
CY2020Q1 vabk Advisory And Brokerage Income
AdvisoryAndBrokerageIncome
178000
CY2019Q1 vabk Advisory And Brokerage Income
AdvisoryAndBrokerageIncome
136000
CY2020Q1 vabk Royalty Income
RoyaltyIncome
47000
CY2019Q1 vabk Royalty Income
RoyaltyIncome
4000
CY2019Q1 us-gaap Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
252000
CY2019Q1 us-gaap Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
81000
CY2019Q1 us-gaap Dividend Income Operating
DividendIncomeOperating
26000
CY2019Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
6475000
CY2019Q1 us-gaap Interest Expense Time Deposits
InterestExpenseTimeDeposits
459000
CY2019Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
86000
CY2019Q1 us-gaap Noninterest Income
NoninterestIncome
1059000
CY2019Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2346000
CY2019Q1 us-gaap Occupancy Net
OccupancyNet
479000
CY2019Q1 us-gaap Equipment Expense
EquipmentExpense
117000
CY2019Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
316000
CY2020Q1 vabk Customer Service Fee Income
CustomerServiceFeeIncome
179000
CY2019Q1 vabk Customer Service Fee Income
CustomerServiceFeeIncome
181000
CY2020Q1 vabk Debit Credit Card And Atm Fee Income
DebitCreditCardAndATMFeeIncome
157000
CY2019Q1 vabk Debit Credit Card And Atm Fee Income
DebitCreditCardAndATMFeeIncome
157000
CY2020Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
107000
CY2019Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
110000
CY2020Q1 vabk Fees On Mortgage Sales
FeesOnMortgageSales
47000
CY2019Q1 vabk Fees On Mortgage Sales
FeesOnMortgageSales
30000
CY2020Q1 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
53000
CY2020Q1 vabk Loan Swap Fee Income
LoanSwapFeeIncome
509000
CY2019Q1 vabk Loan Swap Fee Income
LoanSwapFeeIncome
8000
CY2020Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
82000
CY2020Q1 us-gaap Noninterest Income
NoninterestIncome
1669000
CY2020Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2424000
CY2020Q1 us-gaap Occupancy Net
OccupancyNet
452000
CY2020Q1 us-gaap Equipment Expense
EquipmentExpense
131000
CY2020Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
328000
CY2020Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1208000
CY2019Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1153000
CY2020Q1 us-gaap Noninterest Expense
NoninterestExpense
4543000
CY2019Q1 us-gaap Noninterest Expense
NoninterestExpense
4411000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1736000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1532000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
332000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
286000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1404000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
1246000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.52
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2692803
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2678184
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2694090
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2687098
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-406000
CY2020Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
42000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-448000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
956000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-109000
CY2020Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
11000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
70742000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
102000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
24000
CY2019Q1 vabk Adjustments To Additional Paid In Capital Unrestricted Stock Grants
AdjustmentsToAdditionalPaidInCapitalUnrestrictedStockGrants
424000
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
767000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
72525000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
24000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
15000
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
811000
CY2019Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.30
CY2020Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.30
CY2020Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
765000
CY2019Q1 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
684000
CY2020Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-103000
CY2019Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-68000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
40000
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
34000
CY2020Q1 vabk Depreciation And Other Amortization
DepreciationAndOtherAmortization
518000
CY2019Q1 vabk Depreciation And Other Amortization
DepreciationAndOtherAmortization
464000
CY2020Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
24000
CY2019Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
24000
CY2020Q1 vabk Stock Issued During Period Value Unrestricted Stock
StockIssuedDuringPeriodValueUnrestrictedStock
15000
CY2019Q1 vabk Stock Issued During Period Value Unrestricted Stock
StockIssuedDuringPeriodValueUnrestrictedStock
424000
CY2020Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
205000
CY2019Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
423000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
387000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
302000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2891000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2713000
CY2020Q1 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
53000
CY2019Q1 us-gaap Increase Decrease Of Restricted Investments
IncreaseDecreaseOfRestrictedInvestments
1000
CY2020Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
7109000
CY2020Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
13112000
CY2019Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
967000
CY2020Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
5366000
CY2020Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
20641000
CY2019Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
-6754000
CY2020Q1 vabk Payments For Proceeds From Purchased Loans
PaymentsForProceedsFromPurchasedLoans
-5945000
CY2019Q1 vabk Payments For Proceeds From Purchased Loans
PaymentsForProceedsFromPurchasedLoans
-1406000
CY2020Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
50000
CY2019Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
50000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
89000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
64000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3519000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9012000
CY2020Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
21467000
CY2019Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-37261000
CY2020Q1 vabk Increase Decrease In Certificate Of Deposit And Other Time Deposits
IncreaseDecreaseInCertificateOfDepositAndOtherTimeDeposits
-7542000
CY2019Q1 vabk Increase Decrease In Certificate Of Deposit And Other Time Deposits
IncreaseDecreaseInCertificateOfDepositAndOtherTimeDeposits
21927000
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
102000
CY2020Q1 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
808000
CY2019Q1 us-gaap Payments Of Ordinary Dividends
PaymentsOfOrdinaryDividends
763000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13117000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15995000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12489000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4270000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19085000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18874000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31574000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14604000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
1215000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
813000
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
-568000
CY2019Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
955000
CY2019Q1 vabk Right Of Use Assets Obtained In Exchange For New Operating Lease Liabilities
RightOfUseAssetsObtainedInExchangeForNewOperatingLeaseLiabilities
4279000
CY2020Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
102676000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1207000
CY2020Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1829000
CY2020Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
102054000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4704000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
114095000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
358000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
412000
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
114041000
CY2020Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
37078000
CY2020Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
46
CY2020Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
1829000
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
36771000
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
307000
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1817000
CY2020Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
12000
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
54940000
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
9711000
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
64651000
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
321000
CY2019Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
91000
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
412000
CY2020Q1 us-gaap Pledged Financial Instruments Not Separately Reported Securities Pledged
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledged
5000000
CY2019Q4 us-gaap Pledged Financial Instruments Not Separately Reported Securities Pledged
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledged
5000000
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
5400000
CY2019Q1 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0
CY2020Q1 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
53000
CY2020Q1 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
2400000
CY2019Q4 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
2500000
CY2020Q1 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
84000
CY2019Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
100000
CY2020Q1 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
1254000
CY2020Q1 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
1302000
CY2020Q1 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
1260000
CY2020Q1 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
14000
CY2020Q1 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
2384000
CY2020Q1 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
2432000
CY2020Q1 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
36000
CY2020Q1 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
2390000
CY2020Q1 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
33000
CY2019Q4 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
1295000
CY2019Q4 us-gaap Impaired Financing Receivable With No Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithNoRelatedAllowanceUnpaidPrincipalBalance
1340000
CY2019 us-gaap Impaired Financing Receivable With No Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment
1112000
CY2019 us-gaap Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method
ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod
70000
CY2019Q4 us-gaap Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
2479000
CY2019Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
2524000
CY2019Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
21000
CY2019 us-gaap Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
2661000
CY2019 us-gaap Impaired Financing Receivable Interest Income Accrual Method
ImpairedFinancingReceivableInterestIncomeAccrualMethod
156000
CY2020Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
273000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
299000
CY2020Q1 vabk Financing Receivable Number Of Contracts Modifications Recorded Investment
FinancingReceivableNumberOfContractsModificationsRecordedInvestment
71
CY2020Q1 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
2124000
CY2019Q4 vabk Financing Receivable Number Of Contracts Modifications Recorded Investment
FinancingReceivableNumberOfContractsModificationsRecordedInvestment
70
CY2019Q4 us-gaap Financing Receivable Modifications Recorded Investment
FinancingReceivableModificationsRecordedInvestment
2193000
CY2020Q1 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
5
CY2020Q1 us-gaap Financing Receivable Modifications Pre Modification Recorded Investment2
FinancingReceivableModificationsPreModificationRecordedInvestment2
60000
CY2020Q1 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
60000
CY2019Q1 us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
2
CY2019Q1 us-gaap Financing Receivable Modifications Pre Modification Recorded Investment2
FinancingReceivableModificationsPreModificationRecordedInvestment2
55000
CY2019Q1 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
55000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
36000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4209000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
388000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
118000
CY2020Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
4668000
CY2020Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
2384000
CY2020Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
551575000
CY2018Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
4891000
CY2019 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
2259000
CY2019 us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
202000
CY2019 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
1375000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
21000
CY2019Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
4188000
CY2019Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
2479000
CY2019Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
537054000
CY2020Q1 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
3779000
CY2020Q1 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
550180000
CY2020Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
733000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
3610000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
535923000
CY2019Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
771000
CY2019Q2 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2019-06-13
CY2019Q2 vabk Dividends Paid In Kind Percentage
DividendsPaidInKindPercentage
0.05
CY2019Q2 vabk Dividends Paid In Kind Per Share
DividendsPaidInKindPerShare
0.05
CY2019Q2 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2019-07-05
CY2019Q2 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2019-06-26
CY2020Q1 vabk Dividends Paid In Kind Percentage
DividendsPaidInKindPercentage
0.05
CY2014Q2 vabk Dividends Paid In Kind Percentage
DividendsPaidInKindPercentage
0.05
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.2433
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0462
CY2020Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y6M
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0072
CY2020Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
106783
CY2020Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P8Y8M12D
CY2020Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
37.17
CY2020Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
15101
CY2020Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
39.08
CY2020Q1 vabk Number Of Other Real Estate Owned Properties
NumberOfOtherRealEstateOwnedProperties
0
CY2019Q4 vabk Number Of Other Real Estate Owned Properties
NumberOfOtherRealEstateOwnedProperties
0
CY2020Q1 vabk Realized Gains On Sales And Calls Of Securities
RealizedGainsOnSalesAndCallsOfSecurities
53000
CY2020Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1736000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1532000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3430000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3397000
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y9M21D
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0283
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
204000
CY2019Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
204000
CY2020Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
28000
CY2019Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
36000
CY2020Q1 us-gaap Lease Cost
LeaseCost
232000
CY2019Q1 us-gaap Lease Cost
LeaseCost
240000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
199000
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
196000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
600000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
807000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
767000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
680000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
469000
CY2020Q1 vabk Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
393000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3716000
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
286000

Files In Submission

Name View Source Status
0001564590-20-024212-index-headers.html Edgar Link pending
0001564590-20-024212-index.html Edgar Link pending
0001564590-20-024212.txt Edgar Link pending
0001564590-20-024212-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vabk-10q_20200331.htm Edgar Link pending
vabk-20200331.xml Edgar Link completed
vabk-20200331.xsd Edgar Link pending
vabk-20200331_cal.xml Edgar Link unprocessable
vabk-20200331_def.xml Edgar Link unprocessable
vabk-20200331_lab.xml Edgar Link unprocessable
vabk-20200331_pre.xml Edgar Link unprocessable
vabk-ex101_123.htm Edgar Link pending
vabk-ex311_7.htm Edgar Link pending
vabk-ex312_6.htm Edgar Link pending
vabk-ex321_8.htm Edgar Link pending